nomic alterations that prompted physicians to change therapeutic decisions in 28% of patients tested as part of a prospective study conducted in the US Oncology network. * In May, results from a study conducted by Foundation Medicine presented at the 2014 ASCO Annual Meeting demonstrated that FoundationOne